Pacira Pharmaceuticals Return on Equity (TTM):-112.1% for Dec. 31, 2013
View 4,000+ financial data types
Pacira Pharmaceuticals Return on Equity (TTM) Chart
Pacira Pharmaceuticals Historical Return on Equity (TTM) DataPro Export Data Date Range:
|Data for this Date Range|
|Dec. 31, 2013||-112.1%|
|Sept. 30, 2013||-105.3%|
|June 30, 2013||-93.66%|
|March 31, 2013||-91.31%|
|Dec. 31, 2012||-80.11%|
|Sept. 30, 2012||-93.35%|
|June 30, 2012||-103.7%|
|March 31, 2012||-148.1%|
|Dec. 31, 2011||-319.4%|
|Sept. 30, 2011||747.3%|
|June 30, 2011||233.6%|
|March 31, 2011||133.3%|
|Dec. 31, 2010||73.04%|
|Sept. 30, 2010||86.97%|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
PCRX Return on Equity (TTM) Benchmarks
PCRX Return on Equity (TTM) Range, Past 5 Years
Yahoo 03/01 13:04 ET
Reuters 02/27 07:07 ET
Business Wire 02/26 17:34 ET
Yahoo 02/26 11:20 ET
Zacks 02/26 06:20 ET